搜索临床试验以:干扰素β
总计7518个结果
-
NovartisHuman Genome Sciences Inc.完全的
-
French Innovative Leukemia Organisation完全的
-
National Cancer Institute (NCI)完全的治疗相关的急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | FLT3基因突变 | 伴有 PML-RARA 的急性早幼粒细胞白血病 | 具有 Inv(16)(p13.1q22) 或 t(16;16)(p13.1;q22) 的急性髓性白血病; CBFB-MYH11 | 急性髓性白血病伴 t(8;21); (q22; q22.1); RUNX1-RUNX1T1美国
-
Fundació Institut Germans Trias i PujolClinica Universidad de Navarra, Universidad de Navarra招聘中
-
Boston UniversityNational Institute of Mental Health (NIMH)主动,不招人
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University; Kuni Foundation招聘中
-
The First Hospital of Jilin University完全的
-
National Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)完全的
-
Charite University, Berlin, GermanyGerman Research Foundation; Pfizer; German Federal Ministry of Education and Research完全的复发缓解型多发性硬化症
-
University of WashingtonNational Cancer Institute (NCI); Bayer完全的急性髓性白血病 | 骨髓增生异常综合症 | 骨髓增殖性肿瘤 | 新生骨髓增生异常综合征 | 急性双表型白血病美国
-
Emory UniversityCURE Childhood Cancer, Inc.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
University Hospital TuebingenDermatologic Cooperative Oncology Group完全的
-
National Institute of Allergy and Infectious Diseases...主动,不招人
-
Children's Hospital of PhiladelphiaFriedreich's Ataxia Research Alliance; Vidara Therapeutics Research Ltd完全的
-
University of North Carolina, Chapel HillTibotec Pharmaceutical Limited完全的
-
Dermatologic Cooperative Oncology Group未知治疗 | 佐剂 | III期恶性黑色素瘤 | Interferon Alpha德国
-
National Cancer Institute (NCI)完全的
-
Organon and Co完全的
-
Biogen完全的
-
National Eye Institute (NEI)The Emmes Company, LLC完全的
-
Horizon Pharma Ireland, Ltd., Dublin IrelandFriedreich's Ataxia Research Alliance完全的
-
National Cancer Institute (NCI)暂停
-
Institute of Cancer Research, United Kingdom完全的
-
Hackensack Meridian HealthNational Cancer Institute (NCI)撤销
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)完全的
-
Centre Hospitalier Universitaire, AmiensRoche Pharma AG完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中未经治疗的成人急性髓性白血病 | 原始细胞过多的骨髓增生异常综合征 | 高危骨髓增生异常综合征 | 新生骨髓增生异常综合征 | 急性髓性白血病伴 t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | 急性髓性白血病伴 Inv(16)(p13.1q22); CBFB-MYH11 | 具有 t(16;16)(p13.1;q22) 的急性髓性白血病; CBFB-MYH11 | 投资(16) | t(16;16) | t(8;21)美国
-
BiogenElan Pharmaceuticals完全的
-
Centre Hospitalier Universitaire, Amiens完全的
-
Leiden University Medical CenterUniversity Medical Center Groningen完全的
-
French National Agency for Research on AIDS and...Schering-Plough终止
-
Institute of Hematology & Blood Diseases Hospital...招聘中
-
Mongolian National University of Medical SciencesMongolian National Cancer Center招聘中